ARTICLE | Distillery Therapeutics
Therapeutics: Fibroblast growth factor 1 (FGF1)
March 17, 2016 7:00 AM UTC
Mouse studies suggest FGF1 could help treat non-alcoholic fatty liver disease (NAFLD). In a mouse model of NAFLD, mouse FGF1 decreased hepatic inflammation, hepatic steatosis and liver damage compared...